Pathogenesis of human cytomegalovirus infection and cellular targets

被引:94
|
作者
Gerna, G [1 ]
Baldanti, F [1 ]
Revello, MG [1 ]
机构
[1] IRCCS, Policlin San Matteo, Serv Virol, I-27100 Pavia, Italy
关键词
human cytomegalovirus; endothelial cells; leukocytes; chemokines; atherosclerosis;
D O I
10.1016/j.humimm.2004.02.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In acquired immunodeficiency syndrome patients with human cytomegalovirus (HCMV), disseminated infection, and end-organ disease, autopsy findings show a generalized HCMV infection of endothelial cells. On the other hand, immunocompromised transplanted patients show presence of virus and virus products in peripheral blood leukocytes (PBL), when affected by a disseminated HCMV infection. All diagnostic assays are based on the detection of virus and viral components in PBL or whole blood, including polymorphonuclear leukocytes and monocytes. The interplay between endothelial cells and leukocytes represents the pathogenetic basis for all clinical syndromes originating during disseminated HCMV infections and is the trigger for the transmission of HCMV from mother to fetus during primary infections of pregnant women. The two biologic properties of endothelial cell tropism and leukocyte (polymorphonuclear- and monocyte-) tropism are shared by all recent clinical HCMV isolates, whereas they are missing in laboratory-adapted strains. The potential role of HCMV in the pathogenesis of atherosclerosis both in the immunocompetent (after angioplasty) and the heart transplant patient is receiving support from seroepidemiologic findings, in vivo animal models, in vitro data, and also some clinical observations. The interaction of endothelial cells and leukocytes with subsequent spreading of infection to smooth muscle cells may be a major pathogenetic mechanism at the basis of this important vascular disease.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 50 条
  • [31] Pathogenesis of murine cytomegalovirus infection in neonatal mice
    Trgovcich, J
    Pernjak-Pugel, E
    Tomac, J
    Koszinowski, UH
    Jonjic, S
    CMV-RELATED IMMUNOPATHOLOGY, 1998, 21 : 42 - 53
  • [32] CYTOMEGALOVIRUS-INFECTION - PATHOGENESIS, DIAGNOSIS, AND PREVENTION
    NEUMANNHAEFELIN, D
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (33) : 1251 - 1257
  • [33] CELLULAR RECEPTOR FOR HUMAN CYTOMEGALOVIRUS
    COOPER, NR
    NOWLIN, D
    TAYLOR, HP
    COMPTON, T
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (03) : 56 - 59
  • [34] Cellular Transformation by Human Cytomegalovirus
    Herbein, Georges
    CANCERS, 2024, 16 (11)
  • [35] Human cytomegalovirus: pathogenesis, prevention, and treatment
    Shang, Zifang
    Li, Xin
    MOLECULAR BIOMEDICINE, 2024, 5 (01):
  • [36] Pathogenesis of human cytomegalovirus in the immunocompromised host
    Paul Griffiths
    Matthew Reeves
    Nature Reviews Microbiology, 2021, 19 : 759 - 773
  • [37] PATHOGENESIS OF HUMAN CYTOMEGALOVIRUS DISEASE AND THE KIDNEY
    SISSONS, JGP
    SINCLAIR, JH
    BORYSIEWICZ, LK
    KIDNEY INTERNATIONAL, 1991, 40 : S8 - S12
  • [38] HUMAN CYTOMEGALOVIRUS - PATHOGENESIS AND MODELS OF LATENCY
    SINCLAIR, J
    SISSONS, JGP
    SEMINARS IN VIROLOGY, 1994, 5 (03): : 249 - 258
  • [39] Human cytomegalovirus cell tropism and pathogenesis
    Sinzger, C
    Jahn, G
    INTERVIROLOGY, 1996, 39 (5-6) : 302 - 319
  • [40] Pathogenesis of human cytomegalovirus in the immunocompromised host
    Griffiths, Paul
    Reeves, Matthew
    NATURE REVIEWS MICROBIOLOGY, 2021, 19 (12) : 759 - 773